Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Sucampo Reports First Quarter 2017 Financial Results
May 3, 2017 6:30 AM EDTContinued Revenue Growth
Recent Vtesse Acquisition Bolsters Pipeline
Company Reiterates 2017 Guidance
Company to Host Conference Call Today at 8:30 a.m. EDT
ROCKVILLE, Md., May 03, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the first quarter ended March 31, 2017.
... More